Loading company…
Pulsecare develops medical devices for minimally invasive treatment, including pulsed field ablation systems.
Founded in 2021 and based in Shenzhen, Pulsecare develops medical devices for minimally invasive therapy, including pulsed electric field ablation, ultrasound, radiofrequency, and plasma platforms. In November 2025, it closed a Series A+ round led by Oriza Holdings and Loyal Valley Capital, with Tsinghua Innovation Ventures and Tianfeng Capital participating. The funding will support commercialization and clinical research of its cardiac ablation and renal artery ultrasound systems.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in